David A. Ricks, SVP and President, Lilly Bio-Meds at LILLY ELI & CO (LLY), sold 10,709 shares at $71.51 ($769K) on 2015-02-02, disclosed to the SEC on 2015-02-03.
Scheduled sale ($769k) by SVP and President, Lilly Bio-Meds under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.00 | 5,940 | $428K | 55.6% |
| 2 | $71.51 | 4,769 | $341K | 44.4% |
| Total | $71.78 avg | 10,709 | $769K | 100% |
| Filing → |
| ADBE | BUY | 2025-01-30 | $999K | — | Filing → |
| ADBE | BUY | 2022-09-27 | $337K | — | Filing → |
| LLY | BUY | 2019-10-25 | $1.0M | — | Filing → |